EN
TR
EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL
Öz
m
We aimed to examine the potential beneficial effects of diosmin administration on cisplatin - induced premature ovarian failure (POF) in a rat model
Material and Methods
Twenty-eight rats were divided into four groups. Group A rats (n:7) were determined as the sham group. The remaining rats received an intraperitoneal injection of 1.5 mg/kg/day cisplatin for 10 days to create a POF model. Then, they were randomly divided into 3 subgroups.
Group B was determined as POF group. Group C rats were given 100mg/kg/day diosmin for 10 days simultaneously while creating POF model. Group D rats were given 100mg/kg/day diosmin for 10 days after POF model was created. Twentieth day blood samples were taken and left ovaries were resected for examination.
Results
CIS-induced rats showed reduced levels of SOD, AMH and E2 compared to sham group rats (p<0.05). SOD, AMH and E2 values were not significantly different (p>0.05) between the sham group, group C and D. No significant (p>0.05) difference in FSH value was observed between group C, D and sham groups.
There was no significant (p>0.05) difference in the number of secondary and antral follicles between group C and D compared to the sham group. Primordial follicle count was significantly higher in group C than group B (p<0.05). Primary and total follicle count in group D was significantly (p<0.05) higher than group B.
Conclusion
Diosmin administration after chemotherapy or in combination with chemotherapy has shown helpful efficacy in maintaining the ovarian reserve and the structure of the follicles.
Anahtar Kelimeler
Destekleyen Kurum
Yok
Proje Numarası
Yok
Kaynakça
- Referans1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9. Published 2006 Apr 6. doi:10.1186/1750-1172-1-9
- Referans2. Mauri D, Gazouli I, Zarkavelis G, et al. Chemotherapy Associated Ovarian Failure. Front Endocrinol (Lausanne). 2020;11:572388. Published 2020 Dec 8. doi:10.3389/fendo.2020.572388
- Referans3. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005;28(5):401-416. doi:10.2165/00002018-200528050-00004
- Referans4. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606.
- Referans5. Blumenfeld Z, Evron A. Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol. 2016;28(4):223-229. doi:10.1097/GCO.0000000000000278
- Referans6. Woad KJ, Watkins WJ, Prendergast D, Shelling AN. The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol. 2006;46(3):242-244. doi:10.1111/j.1479-828X.2006.00585.x
- Referans7. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729. doi:10.1200/JCO.1996.14.5.1718
- Referans8. Huwait E, Mobashir M. Potential and Therapeutic Roles of Diosmin in Human Diseases. Biomedicines. 2022;10(5):1076. Published 2022 May 6. doi:10.3390/biomedicines10051076
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Klinik Araştırma
Yayımlanma Tarihi
30 Kasım 2022
Gönderilme Tarihi
24 Ağustos 2022
Kabul Tarihi
5 Eylül 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 12 Sayı: 6
APA
Gürsoy, A., & Sade, A. G. (2022). EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine, 12(6), 912-916. https://doi.org/10.16899/jcm.1166435
AMA
1.Gürsoy A, Sade AG. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine. 2022;12(6):912-916. doi:10.16899/jcm.1166435
Chicago
Gürsoy, Ali, ve Ayşe Gökçen Sade. 2022. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine 12 (6): 912-16. https://doi.org/10.16899/jcm.1166435.
EndNote
Gürsoy A, Sade AG (01 Kasım 2022) EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine 12 6 912–916.
IEEE
[1]A. Gürsoy ve A. G. Sade, “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”, Journal of Contemporary Medicine, c. 12, sy 6, ss. 912–916, Kas. 2022, doi: 10.16899/jcm.1166435.
ISNAD
Gürsoy, Ali - Sade, Ayşe Gökçen. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine 12/6 (01 Kasım 2022): 912-916. https://doi.org/10.16899/jcm.1166435.
JAMA
1.Gürsoy A, Sade AG. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine. 2022;12:912–916.
MLA
Gürsoy, Ali, ve Ayşe Gökçen Sade. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine, c. 12, sy 6, Kasım 2022, ss. 912-6, doi:10.16899/jcm.1166435.
Vancouver
1.Ali Gürsoy, Ayşe Gökçen Sade. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine. 01 Kasım 2022;12(6):912-6. doi:10.16899/jcm.1166435
Cited By
LCZ696 (sacubitril/valsartan) mitigates cyclophosphamide-induced premature ovarian failure in rats; the role of TLR4/NF-κB/NLRP3/Caspase-1 signaling pathway
Life Sciences
https://doi.org/10.1016/j.lfs.2023.121789An overview of different methods to establish a murine premature ovarian failure model
Animal Models and Experimental Medicine
https://doi.org/10.1002/ame2.12477